JMI LABS IS NOW PART OF LEARN MORE

Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada. by Jones RN, Ballow CH, Biedenbach DJ, Deinhart JA and Schentag JJ published in Diagn. Microbiol. Infect. Dis. 1998; 31 (3): 437-451

View on Pubmed